Endothelial function in rheumatoid arthritis

QJM: An International Journal of Medicine

Volumn 111, Issue 4, 2018, Pages 243-247

  Adawi, M ^a   Watad, A ^b,c   Bragazzi, N L ^d   Amital, H ^b,c   Saaida, G ^a   Sirchan, R ^a   Blum, A ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ANTIRHEUMATIC AGENT;

ADULT; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; COMORBIDITY; CONTROLLED STUDY; DAS28; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW-MEDIATED DILATION TEST; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; AGED; CASE CONTROL STUDY; DRUG EFFECT; PATHOPHYSIOLOGY; PROGNOSIS; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 85045504497     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcy010     Document Type: Article

References (31)

1. Cypiene A, Dadoniene J, Miltiniene D, Rinkuniene E, Rugiene R, Stropuviene S, et al. The fact not to ignore: mean blood pressure is the main predictor of increased arterial stiffness in patients with systemic rheumatic diseases. Adv Med Sci 2017; 62:223-9.
2. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006; 45:283-6.
3. Kolber MR, Scrimshaw C. Family history of cardiovascular disease. Can Fam Physician 2014; 60:1016.
4. Sur G, Sur M, Kudor-Szabadi L, Sur L, Sporis D, Sur D. Arterial hypertension-prevalence of risk factors and morbide associations that increase cardiovascular risk. Maedica (Buchar) 2010 Jan; 5:34-40.
5. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cãnizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 2014; 5:444-70.
6. Fagard RH. Smoking amplifies cardiovascular risk in patients with hypertension and diabetes. Diabetes Care 2009; 32: S429-31.
7. Romano-Spica V, Macini P, Fara GM, Giammanco G. GSMS- Working Group on Movement Sciences for Health Italian Society of Hygiene Preventive Medicine and Public Health. Adapted Physical Activity for the Promotion of Health and the Prevention of Multifactorial Chronic Diseases: the Erice Charter. Ann Ig 2015; 27:406-14.
8. Anand SS, Hawkes C, de Souza RJ, Mente A, Dehghan M, Nugent R, et al. Food consumption and its impact on cardiovascular disease: importance of Solutions Focused on the Globalized Food System: a Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol 2015; 66:1590-614.
9. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008; 168:928-35.
10. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care 2013; 40:195-211.
11. Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz RR. Community surveillance for coronary heart disease: the Framingham cardiovascular disease survey. methods and preliminary results. Am J Epidemiol 1974; 100:425-36.
12. Graham IM. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol 2005; 20:430-9.
13. Mazzoccoli G, Notarsanto I, de Pinto GD, Dagostino MP, De Cata A, D'Alessandro G, et al. Anti-tumor necrosis factor-a therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients. Intern Emerg Med 2010; 5:495-500.
14. Sedky Abdou MM, El Desouky SM, Helmy El Kaffas KM, Ahmed Hassan AM. Premature atherosclerosis in systemic sclerosis patients: its relation to disease parameters and to traditional risk factors. Int J Rheum Dis 2017; 20:383-9.
15. Meiszterics Z, Tímár O, Gaszner B, Faludi R, Kehl D, Czirják L, et al. Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and metaanalysis. Rheumatology (Oxford) 2016; 55:2119-30.
16. Vincze M, Dér H, Kerekes G, Szodoray P, Zeher M, Dankó K, et al. Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol 2014; 33:1635-41.
17. Akyel A, Tavil Y, Yayla C, Tufan A, Kaya A, Tezcan ME, et al. Endothelial dysfunction in primary Sjögren syndrome. West Indian Med J 2012; 61:870-2.
18. Wang DG, Tang XW, Fan Y, Leng RX, Ni J, Deng SM, et al. Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis. Inflammation 2014; 37:2067-75.
19. Scarno A, Perrotta FM, Cardini F, Carboni A, Annibali G, Lubrano E, et al. Beyond the joint: subclinical atherosclerosis in rheumatoid arthritis. World J Orthop 2014; 5:328-35.
20. Moroni L, Selmi C, Angelini C, Meroni PL. Evaluation of endothelial function by flow-mediated dilation: a comprehensive review in rheumatic disease. Arch Immunol Ther Exp (Warsz) 2017; 65:463-75.
21. Xu SZ, Wang P, Guan SY, Li HM, Leng RX, Pan HF, et al. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis. Postgrad Med J 2017; 93:260-5.
22. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 2003; 48:72-80.
23. Fan CY, Zhang ZY, Mei YF, Wu CJ, Shen BZ. Impaired brachial artery flow-mediated dilation and increased carotid intimamedia thickness in rheumatoid arthritis patients. Chin Med J (Engl) 2012; 125:832-7.
24. Veselinovic MV, Zivkovic VI, Toncev S, Tasic N, Bogdanovic V, Djuric DM, et al. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. Vasa 2012; 41:343-51.
25. Ahmad S, Garg S, Dhar M, Srivastava S, Biswas D, Barthwal SP, et al. Predictors of atherosclerosis in rheumatoid arthritis. Vasa 2012; 41:353-9.
26. Watanabe T, Takemura M, Sato M, Matsunami H, Seishima M, Shimizu K, et al. Clinical significance of brachial flowmediated dilation in patients with rheumatoid arthritis. Int J Rheum Dis 2014; 17:26-33.
27. Temiz A, Gökmen F, Gazi E, Akbal A, Barutçu A, Bekler A, et al. Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: associations in rheumatoid arthritis patients. Herz 2015; 40: 217-24.
28. Kurt T, Temiz A, Gokmen F, Adam G, Ozcan S, Ozbudak E, et al. Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis? Wien Klin Wochenschr 2015; 127:529-34.
29. Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Végh E, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol 2012; 8:224-34.
30. Nada DW, El Morsy S, Abu-Zaid MH, Aboelhawa MA, Zakaria MA, El Sheikh EA, et al. The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity. Clin Rheumatol 2017; doi: 10.1007/s10067-017-3849-5.
31. Magda SL, Mincu RI, Florescu M, Ciobanu AO, Udrea GF, Cinteza M, et al. The assessment of subclinical cardiovascular dysfunction in treated rheumatoid arthritis. Maedica (Buchar) 2016; 11:267-76.